“NSF remains committed to investing in the scientists, engineers, inventors and students that will lead to the next generation of key innovations that unravel mysteries, solve pressing problems, and drive our nation’s economic and national security.”… ”NSF remains committed to investing in the scientists, engineers, inventors and students that will lead to the next generation …
In the frigid waters surrounding Antarctica, an unusual seasonal cycle occurs. During winter, from March to October, the sun barely rises. As seawater freezes it rejects salts, creating pockets of extra-salty brine where microbes live in winter. In… In the frigid waters surrounding Antarctica, an unusual seasonal cycle occurs. During winter, from March to October, …
Polar experiments reveal seasonal cycle in Antarctic sea-ice algae Read More »
Researchers have genetically engineered a marine microorganism to break down plastic in salt water. The modified organism can break down polyethylene terephthalate (PET), a contributor to microplastic pollution in oceans that is used in everything… Researchers have genetically engineered a marine microorganism to break down plastic in salt water. The modified organism can break down …
Genetically modified bacteria break down plastics in saltwater Read More »
Artificial intelligence chatbots use large language models to generate responses that seemingly mimic the way humans use and understand language, but a new study shows that these models remain vulnerable to mistaking nonsense for natural language… Artificial intelligence chatbots use large language models to generate responses that seemingly mimic the way humans use and understand …
Verbal nonsense reveals limitations of AI chatbots Read More »
New research by an international team of scientists describes the causes for the stalled trend in Arctic Ocean sea-ice loss since 2007. The findings indicate that stronger declines in sea ice will occur when an atmospheric feature known as the Arctic… New research by an international team of scientists describes the causes for the stalled …
New research explains “Atlantification” of the Arctic Ocean Read More »
Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally Munich / London / Athens, March 20th, 2023 – Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH …
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories Read More »
The Emotet comeback continues as threat actors target SCADA systems 28 September 2022: The latest Internet Security Report from the WatchGuard Threat Lab, shows a reduction in overall malware detections from the peaks seen in the first half of 2021, along with an increase in threats for Chrome and Microsoft Office and the ongoing Emotet …
Digital Catapult publishes Sellafield Distributed Ledger Technology Field Lab report Cambridge, UK – July 12, 2022 – Zero trust fabric provider RKVST has shown how it can help safely and securely digitise processes for nuclear waste data tracking, creating a secure, irrefutable way to maintain the integrity of data while ensuring visibility for multiple stakeholders …
RKVST shows the future of nuclear waste tracking with Zero Trust Fabric Read More »
Gaining new market segments in clinical diagnostics – globally unique position as system supplier in laboratory diagnostics sector Darmstadt, June 7, 2022 – R-Biopharm AG, a leading German biotechnology company operating on a global scale, announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer …
Aachen, Germany, and Raleigh, North Carolina – USA, 29 March 2022 – Grünenthal and NovaQuest announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal’s asset resiniferatoxin (RTX). The investigational medicine is being developed with the aim of providing patients suffering from pain associated with osteoarthritis …